- Front Page
- Why us
- Download & Publications
- Contact us
7th Annual Biologics Manufacturing Korea
Cell Line Development
The 7th Annual Biologics Manufacturing Korea will take place May 29-31 in Seoul, Korea at the Hotel Novotel Ambassador Seoul Gangnam and we at Novo Nordisk Pharmatech invite you visit our both (booth #12) to discover more about our recombinant insulin for innovative biologics.
At Novo Nordisk Pharmatech we remain the leading worldwide supplier of recombinant insulin. Our recombinant insulin is a key component in serum free growth media for mammalian cells and approved by regulatory bodies worldwide, including FDA and EMA, and our products are manufactured to cGMP standards, and we guarantee:
- Global regulatory compliance
- Consistent high quality
- Extensive regulatory documentation
- Continuous availability
- Secure global supply chain
- High levels of service and support
We deliver a proven record of product Purity, Reliability and Consistency and can even tailor Quality products for future therapies
Increase viable CHO cell density in commercial available cell culture medium by supplementation with non-animal insulin
CHO cells are one of the most widely used platforms for the production of biopharmaceuticals. Increased demand for safety and reliability has moved the standard for CHO cell culture media from Serum containing to Serum free and further on to chemically defined media. UAB in collaboration with Novo Nordisk Pharmatech (world’s largest supplier of recombinant insulin) has shown that addition of animal origin free insulin to three leading commercially available off-the-shelf chemically defined media resulted in significant increases in viable cell density. In addition to this benefit insulin has been proven to aid in the expression of difficult to express proteins. Please stop by our booth for a talk how insulin could play an important role in your upstream process and for the chance to win an Amazon kindle.
If you want to learn more about our recombinant Insulin Human click here
We look forward to see you at our both and offer you a chance to discover more about our recombinant insulin for innovative biologics.
"The 6th Annual Cell Line Development & Engineering Asia provides a platform to facilitate discussion on accelerating cell line products time to market, increasing efficiency, efficacy and improving quality in the cell line development process."